Prof Ferdinando Nicoletti is the co-founder and Member of the Board of Across Pharmaceuticals. Professor of General Pathology and Immunology, University of Catania (Italy) He serves in the Editorial Boards of several international journals including Antioxidants and Redox Signalling, Basic and Clinical Pharmacology and Toxicology and the European Journal of Pharmacology. Co-founder of GaNiAl Immunotherapeutic Inc. (USA), of Onconox (Copenhagen, Denmark), AURA Biopharm (Oslo, Norway) and Cresence (Olso, Norway). Successful exit with each company; 20 years of collaboration with pharma.
